![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:731374 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RPL37 mRNA | CTD | PMID:22079256 | 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane | affects expression | EXP | | 6480464 | o, p'-DDT affects the expression of RPL37 mRNA | CTD | PMID:17984292 | 1,2-dimethylhydrazine | multiple interactions | ISO | RGD:735424 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RPL37 mRNA | CTD | PMID:22206623 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | RGD:735424 | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:21394737 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RPL37 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RPL37 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:735424 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RPL37 mRNA | CTD | PMID:15328365, PMID:18796159 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:735424 | 6480464 | [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of RPL37 mRNA | CTD | PMID:16214954 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:735424 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RPL37 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:735424 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of RPL37 mRNA | CTD | PMID:19465110 | 3-chloropropane-1,2-diol | decreases expression | EXP | | 6480464 | alpha-Chlorohydrin results in decreased expression of RPL37 mRNA | CTD | PMID:28522335 | 4-amino-2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 4-amino-2, 6-dinitrotoluene affects the expression of RPL37 mRNA | CTD | PMID:21346803 | 5-fluorouracil | decreases expression | ISO | RGD:731374 | 6480464 | Fluorouracil results in decreased expression of RPL37 mRNA | CTD | PMID:16557594 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of RPL37 mRNA | CTD | PMID:31881176 | aluminium atom | decreases expression | ISO | RGD:731374 | 6480464 | Aluminum results in decreased expression of RPL37 mRNA, Aluminum results in decreased expression of RPL37 protein | CTD | PMID:27329587 | aluminium(0) | decreases expression | ISO | RGD:731374 | 6480464 | Aluminum results in decreased expression of RPL37 mRNA, Aluminum results in decreased expression of RPL37 protein | CTD | PMID:27329587 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of RPL37 mRNA | CTD | PMID:16483693 | antirheumatic drug | increases expression | ISO | RGD:731374 | 6480464 | Antirheumatic Agents results in increased expression of RPL37 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | RGD:731374 | 6480464 | aristolochic acid I results in decreased expression of RPL37 protein | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | RGD:731374 | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to RPL37 mRNA], arsenite promotes the reaction [G3BP1 protein binds to RPL37 protein] | CTD | PMID:32406909 | arsenous acid | increases expression | ISO | RGD:731374 | 6480464 | Arsenic Trioxide results in increased expression of RPL37 mRNA | CTD | PMID:20458559 | benzene | decreases expression | EXP | | 6480464 | Benzene results in decreased expression of RPL37 mRNA | CTD | PMID:15878777 | benzo[a]pyrene | increases methylation | ISO | RGD:731374 | 6480464 | Benzo(a)pyrene results in increased methylation of RPL37 3' UTR, Benzo(a)pyrene results in increased methylation of RPL37 promoter | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | increases expression | ISO | RGD:731374 | 6480464 | 7 more ... | CTD | PMID:19150397 | bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:731374 | 6480464 | Diethylhexyl Phthalate results in decreased expression of RPL37 mRNA | CTD | PMID:28412506 | bisphenol A | increases methylation | ISO | RGD:731374 | 6480464 | bisphenol A results in increased methylation of RPL37 gene | CTD | PMID:22576693 | bisphenol A | decreases expression | ISO | RGD:735424 | 6480464 | bisphenol A results in decreased expression of RPL37 mRNA | CTD | PMID:35598803 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of RPL37 mRNA | CTD | PMID:30903817 | bisphenol A | affects expression | ISO | RGD:731374 | 6480464 | bisphenol A affects the expression of RPL37 mRNA | CTD | PMID:30903817 | bisphenol A | decreases expression | ISO | RGD:731374 | 6480464 | bisphenol A results in decreased expression of RPL37 mRNA | CTD | PMID:22576693 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RPL37 mRNA | CTD | PMID:25181051 | cadmium atom | multiple interactions | ISO | RGD:731374 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPL37 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | RGD:731374 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPL37 mRNA | CTD | PMID:35301059 | chromium(6+) | affects expression | ISO | RGD:735424 | 6480464 | chromium hexavalent ion affects the expression of RPL37 mRNA | CTD | PMID:28472532 | clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of RPL37 mRNA | CTD | PMID:17602206 | copper atom | multiple interactions | ISO | RGD:731374 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of RPL37 mRNA | CTD | PMID:20971185 | copper atom | decreases expression | ISO | RGD:731374 | 6480464 | Copper results in decreased expression of RPL37 mRNA, Copper results in decreased expression of RPL37 protein | CTD | PMID:27329587 | copper(0) | multiple interactions | ISO | RGD:731374 | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of RPL37 mRNA | CTD | PMID:20971185 | copper(0) | decreases expression | ISO | RGD:731374 | 6480464 | Copper results in decreased expression of RPL37 mRNA, Copper results in decreased expression of RPL37 protein | CTD | PMID:27329587 | cylindrospermopsin | increases expression | ISO | RGD:735424 | 6480464 | cylindrospermopsin results in increased expression of RPL37 mRNA | CTD | PMID:20936652 | diarsenic trioxide | increases expression | ISO | RGD:731374 | 6480464 | Arsenic Trioxide results in increased expression of RPL37 mRNA | CTD | PMID:20458559 | dibutyl phthalate | decreases expression | ISO | RGD:735424 | 6480464 | Dibutyl Phthalate results in decreased expression of RPL37 mRNA | CTD | PMID:21266533 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of RPL37 mRNA | CTD | PMID:17379624 | dioxygen | increases expression | ISO | RGD:735424 | 6480464 | Oxygen deficiency results in increased expression of RPL37 mRNA | CTD | PMID:24205000 | dorsomorphin | multiple interactions | ISO | RGD:731374 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | multiple interactions | ISO | RGD:731374 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RPL37 mRNA | CTD | PMID:27188386 | epoxiconazole | increases expression | ISO | RGD:735424 | 6480464 | epoxiconazole results in increased expression of RPL37 mRNA | CTD | PMID:35436446 | ethyl methanesulfonate | increases expression | ISO | RGD:731374 | 6480464 | Ethyl Methanesulfonate results in increased expression of RPL37 mRNA | CTD | PMID:23649840 | fenthion | increases expression | ISO | RGD:735424 | 6480464 | Fenthion results in increased expression of RPL37 mRNA | CTD | PMID:34813904 | folic acid | multiple interactions | ISO | RGD:735424 | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in increased expression of RPL37 mRNA | CTD | PMID:22206623 | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of RPL37 mRNA | CTD | PMID:33387578 | iron atom | decreases expression | ISO | RGD:731374 | 6480464 | Iron results in decreased expression of RPL37 mRNA | CTD | PMID:27329587 | iron(0) | decreases expression | ISO | RGD:731374 | 6480464 | Iron results in decreased expression of RPL37 mRNA | CTD | PMID:27329587 | lead(0) | affects expression | ISO | RGD:731374 | 6480464 | Lead affects the expression of RPL37 mRNA | CTD | PMID:28903495 | lead(0) | decreases expression | ISO | RGD:731374 | 6480464 | Lead results in decreased expression of RPL37 mRNA, Lead results in decreased expression of RPL37 protein | CTD | PMID:27329587 | lead(2+) | decreases expression | ISO | RGD:731374 | 6480464 | Lead results in decreased expression of RPL37 mRNA, Lead results in decreased expression of RPL37 protein | CTD | PMID:27329587 | lead(2+) | affects expression | ISO | RGD:731374 | 6480464 | Lead affects the expression of RPL37 mRNA | CTD | PMID:28903495 | manganese atom | decreases expression | ISO | RGD:731374 | 6480464 | Manganese results in decreased expression of RPL37 mRNA | CTD | PMID:27329587 | manganese(0) | decreases expression | ISO | RGD:731374 | 6480464 | Manganese results in decreased expression of RPL37 mRNA | CTD | PMID:27329587 | methidathion | increases expression | ISO | RGD:735424 | 6480464 | methidathion results in increased expression of RPL37 mRNA | CTD | PMID:34813904 | methotrexate | affects expression | ISO | RGD:735424 | 6480464 | Methotrexate affects the expression of RPL37 mRNA | CTD | PMID:18502557 | methyl methanesulfonate | decreases expression | ISO | RGD:731374 | 6480464 | Methyl Methanesulfonate results in decreased expression of RPL37 mRNA | CTD | PMID:23649840 | miconazole | increases expression | ISO | RGD:735424 | 6480464 | Miconazole results in increased expression of RPL37 mRNA | CTD | PMID:27462272 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of RPL37 mRNA | CTD | PMID:17602206 | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of RPL37 mRNA | CTD | PMID:24136188 | pentachlorophenol | increases expression | ISO | RGD:735424 | 6480464 | Pentachlorophenol results in increased expression of RPL37 mRNA | CTD | PMID:23892564 | phenylmercury acetate | decreases expression | ISO | RGD:731374 | 6480464 | Phenylmercuric Acetate results in decreased expression of RPL37 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:731374 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RPL37 mRNA | CTD | PMID:27188386 | pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of RPL37 mRNA | CTD | PMID:16940010 | potassium chromate | multiple interactions | ISO | RGD:731374 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of RPL37 mRNA | CTD | PMID:22079256 | potassium chromate | increases expression | ISO | RGD:731374 | 6480464 | potassium chromate(VI) results in increased expression of RPL37 mRNA | CTD | PMID:22079256 | pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:735424 | 6480464 | Pregnenolone Carbonitrile results in increased expression of RPL37 mRNA | CTD | PMID:28903501 | SB 431542 | multiple interactions | ISO | RGD:731374 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | succimer | multiple interactions | ISO | RGD:731374 | 6480464 | [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RPL37 mRNA | CTD | PMID:26378955 | sunitinib | increases expression | ISO | RGD:731374 | 6480464 | Sunitinib results in increased expression of RPL37 mRNA | CTD | PMID:31533062 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of RPL37 mRNA | CTD | PMID:31150632 | thapsigargin | increases expression | ISO | RGD:731374 | 6480464 | Thapsigargin results in increased expression of RPL37 mRNA | CTD | PMID:22378314 | toluene | decreases expression | EXP | | 6480464 | Toluene results in decreased expression of RPL37 mRNA | CTD | PMID:22166486 | toluene | increases expression | EXP | | 6480464 | Toluene results in increased expression of RPL37 mRNA | CTD | PMID:22166486 | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of RPL37 mRNA | CTD | PMID:33387578 | trichostatin A | decreases expression | ISO | RGD:731374 | 6480464 | trichostatin A results in decreased expression of RPL37 mRNA | CTD | PMID:24935251 | tungsten | increases expression | ISO | RGD:735424 | 6480464 | Tungsten results in increased expression of RPL37 mRNA | CTD | PMID:30912803 | tunicamycin | increases expression | ISO | RGD:731374 | 6480464 | Tunicamycin results in increased expression of RPL37 mRNA | CTD | PMID:22378314, PMID:29453283 | urethane | increases expression | ISO | RGD:731374 | 6480464 | Urethane results in increased expression of RPL37 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | RGD:731374 | 6480464 | Valproic Acid results in decreased expression of RPL37 mRNA | CTD | PMID:23179753 more ... | valproic acid | multiple interactions | ISO | RGD:731374 | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RPL37 mRNA | CTD | PMID:27188386 | vorinostat | decreases expression | ISO | RGD:731374 | 6480464 | Vorinostat results in decreased expression of RPL37 mRNA | CTD | PMID:27188386 | |